Emergent BioSolutions Inc. EBS
5.05 USD -0.10 (-1.94%)
Regular-session close
5.05 0.00 0.00%
After hours · Nov 20, 4:00 PM ET
4.98 Day range 5.24
4.36 52-week range 14.06
- YTD
- -59.14%
- 1 year
- -44.38%
Revenue & Expenses
Revenue by
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 742.90M | 1.04B | 1.05B | 1.12B | 1.77B | |
| 416.70M | 362.30M | 343.90M | 424.40M | 1.03B | |
| 100.10M | -108.70M | -726.40M | -170.00M | 341.40M | |
| 52.60M | -190.60M | -760.50M | -211.60M | 219.50M | |
| 0.93 | -3.60 | -14.85 | -4.22 | 4.06 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 209.10M | 105.60M | 111.70M | 642.60M | 576.30M | |
| 1.32B | 1.39B | 1.82B | 3.17B | 2.96B | |
| 796.00M | 906.90M | 1.17B | 1.78B | 1.35B | |
| 572.10M | 663.70M | 860.20M | 1.41B | 841.00M | |
| 522.60M | 482.80M | 649.30M | 1.39B | 1.61B |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 170.60M | 58.70M | -206.30M | -34.10M | 320.20M | |
| 69.40M | 125.20M | 212.30M | -381.30M | -224.10M | |
| -136.60M | -190.00M | -535.70M | 481.20M | -141.00M | |
| 24.40M | -15.00M | -51.60M | -115.80M | -224.10M | |
| 103.50M | -6.10M | -530.90M | 66.30M | -45.20M |
